All the studies discussed suggest that FGF-21, FGF-19 and FGF-23 may play an important role in fetal and neonatal growth and development, particularly in pregnancies complicated by metabolic disorders, such as GDM or gestational hypertension. This evidence concerns the gene FGF23 and metabolic disease.